Latest filing published 07 Dec 2020 for Regulus Therapeutics Inc., €2.3M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Growth Equity Opportunities V, LLC: trading record in brief
Growth Equity Opportunities V, LLC is a declared insider of Regulus Therapeutics Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 7 May 2019 to 4 December 2020, the count stands at 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €3.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2020: 1 purchase and no sales on the market.
The record was last updated on 7 December 2020 with an open-market purchase (€2.3M) in Regulus Therapeutics Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Growth Equity Opportunities V, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ▲
Same trade as the filing by Forest Baskett, counted once
3M USD31SEC4,398,602 shares@ US$0.622100.0% of flowCommon StockSEC:0001209191-20-061962:0Canonical exit: 4 Mar 2021 (T+90) - 1,136,704 shares@ US$1.0832.7% of flowCommon StockSEC:0001209191-19-028589:0Canonical exit: 5 Aug 2019 (T+90)
2 of 1 declaration
